Impact of SARS-CoV-2 Infection on Disease Trajectory in Youth with T1D: An EHR-Based Cohort Study from the RECOVER Program
Pediatric Diabetes · 09.08.2023 · 2023 · 1-10
DOI: 10.1155/2023/8798997 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pediatric Diabetes, erschienen am 09.08.2023. Verfasst von Priya Prahalad und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics (Endocrinology), Stanford University School of Medicine, Stanford, CA, USA. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) is associated with worsening diabetes trajectory. It is unknown whether PASC in children with type 1 diabetes (T1D) manifests as worsening diabetes trajectory.
Objective
To explore the association between SARS-CoV-2 infection (COVID-19) and T1D-related healthcare utilization (for diabetic ketoacidosis (DKA) or severe hypoglycemia (SH)) or hemoglobin (Hb) A1c trajectory.
Methods
We included children
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics (Endocrinology), Stanford University School of Medicine, Stanford, CA, USA.
- Applied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- Department of Biostatistics, Epidemiology and Informatics, The University of Pennsylvania, Philadelphia, PA, USA.
- Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH, USA.
- Combined Internal Medicine Section, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, OH, USA.
- Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Priya Prahalad
Förderung
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Prahalad, P., Lorman, V., Wu, Q., Razzaghi, H., Chen, Y., Pajor, N., Case, A., Bose-Brill, S., Block, J., Patel, P. B., Rao, S., Mejias, A., Forrest, C. B., Bailey, L. C., Jhaveri, R., Thacker, D., Christakis, D. A., Lee, G. M., & Consortium, O. B. O. T. R. (2023). Impact of SARS-CoV-2 Infection on Disease Trajectory in Youth with T1D: An EHR-Based Cohort Study from the RECOVER Program. Pediatric Diabetes, 2023, 1-10. https://doi.org/10.1155/2023/8798997
Vancouver
Prahalad P, Lorman V, Wu Q, Razzaghi H, Chen Y, Pajor N, et al. Impact of SARS-CoV-2 Infection on Disease Trajectory in Youth with T1D: An EHR-Based Cohort Study from the RECOVER Program. Pediatric Diabetes. 2023;2023:1-10. doi:10.1155/2023/8798997
BibTeX
@article{Prahalad2023,
author = {Prahalad, Priya and Lorman, Vitaly and Wu, Qiong and Razzaghi, Hanieh and Chen, Yong and Pajor, Nathan and Case, Abigail and Bose-Brill, Seuli and Block, Jason and Patel, Payal B and Rao, Suchitra and Mejias, Asuncion and Forrest, Christopher B and Bailey, L Charles and Jhaveri, Ravi and Thacker, Deepika and Christakis, Dimitri A and Lee, Grace M and Consortium, On Behalf Of The Recover},
title = {Impact of SARS-CoV-2 Infection on Disease Trajectory in Youth with T1D: An EHR-Based Cohort Study from the RECOVER Program},
journal = {Pediatric Diabetes},
year = {2023},
volume = {2023},
pages = {1--10},
doi = {10.1155/2023/8798997}
}
EUVIMED